Stephenson, Kevin G. http://orcid.org/0000-0002-5196-9407
Fenning, Rachel M.
Macklin, Eric A.
Lu, Frances
Norris, Megan
Steinberg-Epstein, Robin
Butter, Eric M.
Funding for this research was provided by:
Health Resources and Services Administration (UA3 MC11054)
Article History
Accepted: 11 July 2022
First Online: 25 July 2022
Declarations
:
: Dr. Macklin reported serving on advisory boards for Biogen, Cerevance, and Stoparkinson Healthcare Systems, serving on data monitoring boards for Novartis and Takeda Pharmaceutical, and receipt by his institution of research funds on his behalf from Amylyx Pharmaceuticals, Biohaven Pharmaceuticals, Clene Nanomedicine, GlaxoSmithKline, Mitsubishi Tanabe Pharma America, Prilenia Therapeutics, Ra Pharmaceuticals, and the National Institutes of Health.